News from protein sciences corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 29, 2014, 10:07 ET
Protein Sciences Corporation is saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals (PRNewsFoto/Protein Sciences Corporation)

Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season

 Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been...

Sep 16, 2014, 07:07 ET
Protein Sciences Corporation is saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals (PRNewsFoto/Protein Sciences Corporation)

Protein Sciences and Diamyd Medical Deepen Commitment to Develop New Treatment for Diabetes

 Protein Sciences Corporation and Diamyd Medical AB announced today that Protein Sciences has broadened its commitment to diabetes and become a...

Aug 19, 2014, 10:07 ET
Protein Sciences Corporation is saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals (PRNewsFoto/Protein Sciences Corporation)

Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide

 Protein Sciences Corporation and Passport Health announced today that Flublok® influenza vaccine will be available this fall at all 230+...

Aug 12, 2014, 10:07 ET
Protein Sciences Corporation is saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals (PRNewsFoto/Protein Sciences Corporation)

Protein Sciences and Liomont Announce Licensing of Proprietary Influenza Vaccines for the Mexico Market

 Protein Sciences Corporation and Laboratorios Liomont, S.A. de C.V. (Liomont), a leading Mexican pharmaceutical company, announced today that...

Jul 17, 2014, 10:07 ET
Protein Sciences Corporation is saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals (PRNewsFoto/Protein Sciences Corporation)

Protein Sciences and Partners Launch Health-At-Work to Bring Flublok® and Other Vaccines to the Workplace

 Protein Sciences Corporation announced today that they have partnered with physicians from Velocity Urgent Care and launched a new initiative...

Jul 08, 2014, 10:15 ET
Protein Sciences Corporation is saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals (PRNewsFoto/Protein Sciences Corporation)

Protein Sciences Receives Approval from FDA for 2014/15 Formulation of Flublok® Influenza Vaccine

 Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza...

Jun 17, 2014, 10:18 ET
Protein Sciences Corporation is saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals (PRNewsFoto/Protein Sciences Corporation)

U.S. Biomedical Advanced Research and Development Authority (BARDA) Extends Contract with Protein Sciences Corporation

Protein Sciences Corporation announced today that BARDA, within the U.S. Department of Health and Human Services, exercised Option Period 2 of its...

Jun 10, 2014, 12:02 ET

Protein Sciences Adds Distributor for Flublok® Recombinant Influenza Vaccine to Increase Access

Protein Sciences Corporation announced it will have more doses, earlier availability and broader distribution coverage of its modern, egg-free...

May 30, 2014, 12:10 ET

Protein Sciences Partners File for Marketing Approval of Flublok® Influenza Vaccine in Japan

Protein Sciences Corporation announced today that Astellas Pharma has submitted an application for marketing approval of recombinant influenza HA...

May 21, 2014, 09:34 ET

Protein Sciences CEO Awarded Honorary Degree for Achievements in Science and Business

Protein Sciences Corporation President and CEO, Dr. Manon Cox, MBA, received the degree of Doctor of Humane Letters, honoris causa from The...

Nov 13, 2013, 16:01 ET

Flublok® Influenza Vaccine Now Available!

 Protein Sciences Corporation, the manufacturer of Flublok, the new, pure influenza vaccine containing no egg proteins, influenza virus,...

Oct 10, 2013, 09:30 ET

Flublok® Influenza Vaccine Availability Update: Product to be available to allow vaccination by Thanksgiving

 Protein Sciences Corporation announced today that they expect the first doses of Flublok influenza vaccine for the 2013/2014...

Jun 21, 2013, 16:21 ET

ACIP Unanimously Recommends Flublok® Influenza Vaccine as the Preferred Choice for Adults with Egg Allergies

 Protein Sciences announced today that the Advisory Committee on Immunization Practices (ACIP), which advises the U.S. Centers for Disease...

May 02, 2013, 10:11 ET

Protein Sciences Prepared to Combat the Latest Potential Pandemic Flu Virus

 Protein Sciences announced today that it had completed development of the vector required to manufacture a vaccine to protect against the new...

Feb 20, 2013, 14:53 ET

Meriden Department of Health & Human Services to Host Free Flublok® Influenza Vaccine Clinic Thursday February 21th, 2013

 The Meriden Department of Health and Human Services will host a free walk-in Flublok influenza vaccine clinic on Thursday, February 21, from...

Feb 20, 2013, 09:51 ET

Dr. Wayne Hachey Joins Protein Sciences' Leadership Team

 Protein Sciences Corporation announced today that Wayne Hachey, DO (Colonel, U.S. Army, ret.) has joined the Company's management as Head,...

Feb 15, 2013, 16:15 ET

BARDA Continues Support of Flublok® and Panblok® Influenza Vaccines

 At a press conference today showcasing Protein Sciences' newly leased manufacturing facility for Flublok, the Company announced that the...

Jan 16, 2013, 18:26 ET

U.S. FDA Approves Flublok®, the World's First Recombinant, Highly Purified, Egg-Free Influenza Vaccine

  - The U.S. FDA approved Flublok for people 18-49 years old – making it the first recombinant vaccine for influenza available on...

Nov 30, 2012, 11:19 ET

Protein Sciences Corporation Expands Manufacturing Operations to Pearl River, New York

 Protein Sciences Corporation, makers of Flublok®, the world's first recombinant influenza vaccine, announced today it signed a five year...

Oct 24, 2012, 09:00 ET

Tim Fields, VP Quality, Receives Ken Chapman Industry Recognition Award

Protein Sciences announced that Tim Fields, Vice President of Quality, was named recipient of the Ken Chapman Industry Recognition Award during the...